Jacob Asset Management Of New York LLC Imv Inc. Transaction History

Jacob Asset Management Of New York LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.56 - $1.45 $1,960 - $5,075	-3,500 Reduced 1.63%	211,500 $138,000
Q4 2021 Feb 09, 2022	BUY	$1.22 - $1.78 $73,200 - $106,800	60,000 Added 38.71%	215,000 $262,000
Q3 2021 Nov 12, 2021	SELL	$1.35 - $2.16 $60,750 - $97,200	-45,000 Reduced 22.5%	155,000 $257,000
Q1 2021 Oct 04, 2021	BUY	$2.92 - $4.41 $394,200 - $595,350	135,000 Added 207.69%	200,000 $664,000
Q4 2020 Oct 04, 2021	BUY	$2.9 - $4.4 $188,500 - $286,000	65,000 New	65,000 $200,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.